The role of marine n-3 fatty acids in improving cardiovascular health: a review (Q38074607)

28 August 2017

1 reference

title

The role of marine n-3 fatty acids in improving cardiovascular health: a review (English)

1 reference

28 August 2017

0 references

1 reference

Tiffany Nicholson

1

1 reference

PubMed ID

23325431

28 August 2017

Haidar Khademi

series ordinal

2

1 reference

PubMed ID

23325431

28 August 2017

Mohammed H Moghadasian

series ordinal

3

1 reference

28 August 2017

16 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

4

1 reference

28 August 2017

3

1 reference

28 August 2017

357-365

1 reference

Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy

28 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Prostaglandins and leukotrienes: advances in eicosanoid biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease--eat fish or take fish oil supplement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

The effect of lean fish consumption on triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

(n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

The pathogenesis of atherosclerosis--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Blood pressure lowering effect of eicosapentaenoic acid-rich diet in normotensive, hypertensive and hyperlipemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Dietary protein level interacts with omega-3 polyunsaturated fatty acid deficiency to induce hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Moderate consumption of fatty fish reduces diastolic blood pressure in overweight and obese European young adults during energy restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Mortality from ischaemic heart disease and cerebrovascular disease in Greenland

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Cardiovascular risk and the omega-3 index

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

The differential effects of EPA and DHA on cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30235G

21 January 2018

Identifiers

DOI

10.1039/C2FO30235G

1 reference

28 August 2017

1 reference

PubMed ID

23325431